CD4 and neoplasm: Alternative immune approaches include utilizing tumor-associated antigens (TAAs) that stimulate cellular or humoral responses and can efficiently eliminate tumor cells in some cases (Mittal et al., 2014), since peptides derived from TAAs can be presented with MHC class I/II by CD8+/CD4+ T cells, respectively.